Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends
- PMID: 36927966
- PMCID: PMC10824640
- DOI: 10.2169/internalmedicine.1551-23
Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends
Abstract
Gastroesophageal reflux disease (GERD) is caused by the reflux of gastric contents into the esophagus due to a decline in esophageal clearance and anti-reflux barrier mechanisms. Mucosal injury is caused by a combination of gastric juice directly damaging the esophageal mucosa and the immune and inflammatory mechanism in which inflammatory cytokines released from the esophageal mucosal epithelium cause neutrophil migration, triggering inflammation. Gastric secretion inhibitors are the first-line treatment for GERD, but they can be combined with prokinetic agents and Chinese herbal remedies. However, pharmacotherapy cannot improve anatomical problems or prevent physical causes of GERD, such as reflux of non-acidic contents. Therefore, surgery can be warranted, depending on the pathology. Intraluminal endoscopic therapy, which is both less invasive and more effective than surgery, was recently developed and applied in Europe and the United States. In Japan, intraluminal endoscopic therapies, such as anti-reflux mucosectomy, anti-reflux mucosal ablation, and endoscopic submucosal dissection, for GERD have been independently developed.
Keywords: anti-reflux mucosal ablation (ARMA); endoscopic submucosal dissection for GERD (EGD-G); gastroesophageal reflux disease (GERD); intraluminal endoscopic therapy; potassium-competitive acid blocker (P-CAB); proton pump inhibitor (PPI).
Conflict of interest statement
Figures
References
-
- Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900-1920; quiz 1943, 2006. - PubMed
-
- Smout AJ, Bredenoord AJ. GERD: a challenge to our view of reflux oesophagitis pathogenesis. Nat Rev Gastroenterol Hepatol 13: 504-505, 2016. - PubMed
-
- Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux - damaged human esophageal epithelium. Gastroenterology 111: 1200-1205, 1996. - PubMed
-
- Miwa H, Kondo T, Oshima T. Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment. Curr Opin Gastroenterol 32: 344-352, 2016. - PubMed
-
- Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137: 1776-1784, 2009. - PubMed
